Fatigue and weakness may occur, particularly during the initial treatment period as the body adjusts to the metabolic effects of the medication
The cyclic structure can protect against enzymatic degradation while maintaining biological activity, potentially expanding the range of conditions treatable with peptide therapeutics
Peptide-based therapies often reduce appetite and help control cravings
Kaser A, Lee AH, Franke A, Glickman JN, Zeissig S, Tilg H, et al
Odago, F
For example, the chronic use of non-steroidal anti-inflammatory drugs (NSAIDs) may lead to gastric mucosal damage, whereas there are various side effects of the immunosuppressive drugs and corticosteroids, such as increased skin fragility and reduced bone marrow (Jantan et al., 2021)